Insulin Metabolism and Protein Degradation by HEPG2 Hepatocytes Treated with HIV-Protease Inhibitors
Class of 2007 Abstract === Objectives: To explore the effects of human immunodeficiency virus protease inhibitors (HPI) on insulin metabolism and protein degradation in HepG2 hepatocytes in vitro. Methods: To see if HIV-protease inhibitors affect insulin degradation in a dose-dependent manner, HepG...
Main Author: | Tsui, Brian |
---|---|
Other Authors: | Vaillancourt, Richard |
Language: | en_US |
Published: |
The University of Arizona.
2007
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/624329 http://arizona.openrepository.com/arizona/handle/10150/624329 |
Similar Items
-
Current and Novel Inhibitors of HIV Protease
by: Jan Konvalinka, et al.
Published: (2009-12-01) -
Oral candidiasis in HIV+ patients under treatment with protease inhibitors
by: Andréa Lusvarghi Witzel, et al.
Published: (2008-12-01) -
Redistribuição da gordura corporal induzida pelos inibidores de protease em pacientes com Aids Redistribution of body fat induced by HIV protease inhibitors in patients with AIDS
by: Cristina Mansur, et al.
Published: (2006-10-01) -
HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment
by: Unaí Tupinambás, et al. -
Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease
by: Sibusiso Maseko, et al.
Published: (2019-01-01)